MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) (“bioAffinity” or the “Company”), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and ...

Affinity Technologies (BIAF) announced that William Bauta, Ph.D., has been appointed Chief Science Officer. Before joining bioAffinity in ...

Before joining bioAffinity in 2016 as Senior Vice President of Research and Development, Dr. Bauta was the Associate Director of Science at Genzyme Corporation and held a similar position at Ilex ...

Before joining bioAffinity in 2016 as Senior Vice President of Research and Development, Dr. Bauta was the Associate Director of Science at Genzyme Corporation and held a similar position at Ilex ...

Strategic Collaborations: The company's ability to establish and maintain collaborations, such as the prior agreement with ...

Dr. Bauta, previously serving as the Senior Vice President of Research and Development, has a background that includes positions at Genzyme Corporation and Ilex Products, Inc., where he was ...

Moleculin Biotech, Inc., (Moleculin or the Company), a late stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the ...

About the author: Jennifer Wound is a senior product manager for global marketing at Genzyme Corporation, a subsidiary of Sanofi. She recently helped to develop "Facing Fabry Together," a rare ...